Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial
published in: Lancet Oncology Commission
date of publication: 2013-05-09
main subject: phase III clinical trial, aclarubicin, multicenter clinical trial, leukemia
Cites articles 17
Date
Title
Article - wd:Q45111985